-
EP3494116
European procedure
Extract from the Register of European Patents
EP About this file: EP3494116
| EP3494116 - ESTROGEN RECEPTOR MODULATORS [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 28.08.2020 Database last updated on 03.05.2025 | |
| Former | The patent has been granted Status updated on 20.09.2019 | ||
| Former | Grant of patent is intended Status updated on 17.09.2019 | ||
| Former | Examination is in progress Status updated on 05.08.2019 | ||
| Former | Grant of patent is intended Status updated on 25.06.2019 | ||
| Former | Examination is in progress Status updated on 09.04.2019 | ||
| Former | The international publication has been made Status updated on 04.08.2018 | ||
| Former | unknown Status updated on 27.02.2018 | Most recent event Tooltip | 28.08.2020 | No opposition filed within time limit | published on 30.09.2020 [2020/40] | Applicant(s) | For all designated states Astrazeneca AB 151 85 Södertälje / SE | [2019/24] | Inventor(s) | 01 /
SCOTT, James, Stewart AstraZeneca, Darwin Building Cambridge Science Park Milton Road Cambridgeshire CB4 0WG / GB | 02 /
MOSS, Thomas, Andrew AstraZeneca Darwin Building, Cambridge Science Park Milton Road Cambridgeshire CB4 0WG / GB | 03 /
HUGHES, Samantha, Jayne AstraZeneca Darwin Building, Cambridge Science Park Milton Road Cambridge, Cambridgeshire CB4 0WG / GB | 04 /
NISSINK, Johannes, Wilhelmus, Maria AstraZeneca Darwin Building, Cambridge Science Park Milton Road Cambridge, Cambridgeshire CB4 0WG / GB | 05 /
BARLAAM, Bernard, Christophe AstraZeneca Darwin Building, Cambridge Science Park Milton Road Cambridge, Cambridgeshire CB4 0WG / GB | 06 /
YANG, Bin AstraZeneca 35 Gatehouse Drive Waltham, MA 02451 / US | [2019/43] |
| Former [2019/34] | 01 /
SCOTT, James, Stewart AstraZeneca, Darwin Building Cambridge Science Park Milton Road Cambridgeshire CB4 0WG / GB | ||
| 02 /
MOSS, Thomas, Andrew AstraZeneca Darwin Building, Cambridge Science Park Milton Road Cambridgeshire CB4 0WG / GB | |||
| 03 /
HUGHES, Samantha, Jayne AstraZeneca Darwin Building, Cambridge Science Park Milton Road Cambridge, Cambridgeshire CB4 0WG / GB | |||
| 04 /
NISSINK, Johannes, Wilhelmus, Maria AstraZeneca Darwin Building, Cambridge Science Park Milton Road Cambridge, Cambridgeshire CB4 0WG / GB | |||
| 05 /
BARLAAM, Bernard, Christophe AstraZeneca Darwin Building, Cambridge Science Park Milton Road Cambridge, Cambridgeshire CB4 0WG / GB | |||
| 06 /
YANG, Bin AstraZeneca 35 Gatehouse Drive Waltham, MA 02451 / US | |||
| Former [2019/26] | 01 /
SCOTT, James, Stewart AstraZeneca, Darwin Building Cambridge Science Park Milton Road Cambridge/Cambridgeshire CB4 0WG / GB | ||
| 02 /
MOSS, Thomas, Andrew AstraZeneca, Darwin Building Cambridge Science Park Milton Road Cambridge/Cambridgeshire CB4 0WG / GB | |||
| 03 /
HUGHES, Samantha, Jayne AstraZeneca, Darwin Building Cambridge Science Park Milton Road Cambridge, Cambridgeshire CB4 0WG / GB | |||
| 04 /
NISSINK, Johannes, Wilhelmus, Maria AstraZeneca Darwin Building, Cambridge Science Park Milton Road Cambridge, Cambridgeshire CB4 0WG / GB | |||
| 05 /
BARLAAM, Bernard, Christophe AstraZeneca Darwin Building, Cambridge Science Park Milton Road Cambridge, Cambridgeshire CB4 0WG / GB | |||
| 06 /
YANG, Bin AstraZeneca 35 Gatehouse Drive Waltham MA 02451 / US | |||
| Former [2019/24] | 01 /
SCOTT, James, Stewart AstraZeneca Darwin Building Cambridge Science Park Milton Road Cambridge CB4 0WG / GB | ||
| 02 /
MOSS, Thomas, Andrew AstraZeneca Darwin Building Cambridge Science Park Milton Road Cambridgeshire CB4 0WG / GB | |||
| 03 /
HUGHES, Samantha, Jayne AstraZeneca Darwin Building Cambridge Science Park Milton Road Cambridge Cambridgeshire CB4 0WG / GB | |||
| 04 /
NISSINK, Johannes, Wilhelmus, Maria AstraZeneca Darwin Building Cambridge Science Park Milton Road Cambridge Cambridgeshire CB4 0WG / GB | |||
| 05 /
BARLAAM, Bernard, Christophe AstraZeneca Darwin Building Cambridge Science Park Milton Road Cambridge Cambridgeshire CB4 0WG / GB | |||
| 06 /
YANG, Bin AstraZeneca 35 Gatehouse Drive Waltham MA 02451 / US | Representative(s) | AstraZeneca Intellectual Property Eastbrook House Shaftesbury Road Cambridge CB2 8BF / GB | [N/P] |
| Former [2019/24] | AstraZeneca Milstein Building Granta Park Cambridge CB21 6GH / GB | Application number, filing date | 18705097.6 | 29.01.2018 | [2019/24] | WO2018EP52040 | Priority number, date | US201762451971P | 30.01.2017 Original published format: US 201762451971 P | US201762523695P | 22.06.2017 Original published format: US 201762523695 P | US201762560304P | 19.09.2017 Original published format: US 201762560304 P | US201762592485P | 30.11.2017 Original published format: US 201762592485 P | [2019/24] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2018138303 | Date: | 02.08.2018 | Language: | EN | [2018/31] | Type: | A1 Application with search report | No.: | EP3494116 | Date: | 12.06.2019 | Language: | EN | The application published by WIPO in one of the EPO official languages on 02.08.2018 takes the place of the publication of the European patent application. | [2019/24] | Type: | B1 Patent specification | No.: | EP3494116 | Date: | 23.10.2019 | Language: | EN | [2019/43] | Search report(s) | International search report - published on: | EP | 02.08.2018 | Classification | IPC: | C07D471/04, A61P35/00, A61K31/437, A61K31/506, A61K31/501 | [2019/24] | CPC: |
C07D471/04 (EP,IL,KR,US);
A61K31/407 (EP,KR,US);
A61K31/437 (EP,IL,KR,US);
A61P35/00 (EP,IL,KR,US)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2019/24] | Extension states | BA | 07.03.2019 | ME | 07.03.2019 | Validation states | MA | 07.03.2019 | MD | 07.03.2019 | TN | 07.03.2019 | Title | German: | ÖSTROGEN-REZEPTOR-MODULATOREN | [2019/24] | English: | ESTROGEN RECEPTOR MODULATORS | [2019/24] | French: | MODULATEURS DU RÉCEPTEUR DES OESTROGÈNES | [2019/24] | Entry into regional phase | 07.03.2019 | National basic fee paid | 07.03.2019 | Designation fee(s) paid | 07.03.2019 | Examination fee paid | Examination procedure | 07.03.2019 | Amendment by applicant (claims and/or description) | 07.03.2019 | Examination requested [2019/24] | 07.03.2019 | Date on which the examining division has become responsible | 12.04.2019 | Despatch of a communication from the examining division (Time limit: M02) | 21.05.2019 | Reply to a communication from the examining division | 26.06.2019 | Communication of intention to grant the patent | 02.08.2019 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 02.08.2019 | Fee for grant paid | 02.08.2019 | Fee for publishing/printing paid | 17.09.2019 | Information about intention to grant a patent | 17.09.2019 | Receipt of the translation of the claim(s) | Divisional application(s) | EP19203383.5 / EP3689873 | Opposition(s) | 24.07.2020 | No opposition filed within time limit [2020/40] |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [A]US2012157402 (CAO LIANGXIAN [US], et al); | [I]US2014357661 (BRADBURY ROBERT HUGH [GB], et al); | [I]US2016175289 (LABADIE SHARADA [US], et al); | [IP]US2018021316 (SCOTT JAMES STEWART [GB], et al) | by applicant | US4683195 | US4683202 |